Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
31%
ALSO IN XPH
XPH
47
HOLDINGS
32%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.4% | 2.7% | 2.7% |
|
PFIZER INC | 7.0% | 2.5% | 2.5% |
|
ELI LILLY & CO | 3.6% | 2.5% | 2.5% |
|
ZOETIS INC | 3.4% | 2.5% | 2.5% |
|
BRISTOL-MYERS SQUIBB CO | 6.9% | 2.4% | 2.4% |
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.7% |
|
JOHNSON & JOHNSON | 4.8% |
|
PFIZER INC | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% |
|
MERCK & CO. INC. | 4.4% |
|
CARDINAL HEALTH INC | 3.8% |
|
BIOGEN IDEC INC | 3.7% |
|
GILEAD SCIENCES INC | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.6% |
FTXH Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.4% |
|
TARSUS PHARMACEUTICALS, INC. | -2.7% |
|
HARROW INC | -2.6% |
|
ORGANON & CO. | -2.6% |
|
ROYALTY PHARMA PLC CLASS A | -2.5% |
|
OCULAR THERAPEUTIX INC | -2.5% |
|
BIOSANTE PHARMACEUTICALS INC | -2.5% |
|
CORCEPT THERAPEUTICS INC | -2.5% |
|
AXSOME THERAPEUTICS, INC. | -2.5% |
|
INNOVIVA, INC. | -2.4% |